ArticleBlood2022

Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.

Jenny N H G Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.